Shenzhen Wudian Technology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Shenzhen Wudian Technology Co., Ltd. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 8 (Hand Tools) — 5 filings in this category. Currently, 3 trademarks are registered. Notable registered marks include YOUGSH, FULLIFE, and COSPRAIN. The owner is based in Shenzhen.

2-3/F, Build.5, Yali Industrial Park,

Shiyan St., Bao'an Dist.,

Shenzhen 518000 , CN

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

YOUGSH
YOUGSH
Registered 2022
COSPRAIN
COSPRAIN
Registered 2019
FULLIFE
FULLIFE
Registered 2019

Trademark Classifications

Shenzhen Wudian Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

8
Hand Tools (5 filings)

Hand tools and implements (hand-operated); cutlery; side arms; razors

Frequently Asked Questions

How many trademarks does Shenzhen Wudian Technology Co., Ltd. have?

Shenzhen Wudian Technology Co., Ltd. has 5 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does Shenzhen Wudian Technology Co., Ltd. file in?

Shenzhen Wudian Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 8 (Hand Tools). Class 8 covers hand tools and implements (hand-operated); cutlery; side arms; razors.

What are Shenzhen Wudian Technology Co., Ltd.'s most well-known trademarks?

Shenzhen Wudian Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as YOUGSH, FULLIFE, and COSPRAIN. These are among 3 currently registered trademarks in the portfolio.

What is Shenzhen Wudian Technology Co., Ltd.'s trademark registration success rate?

Shenzhen Wudian Technology Co., Ltd. has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.